News
Patients self-inject them once a week, though a GLP-1 pill may be on the horizon. Mounjaro and Ozempic are approved to treat Type 2 diabetes. Zepbound and Wegovy are approved to treat obesity.
A large review of studies compared GLP-1 agonist medications, including semaglutide, for lowering people’s risk of cardiovascular problems. (Semaglutide is the active ingredient in Ozempic and ...
Over the past few years, GLP-1 medications, which have historically been used to treat type 2 diabetes, have become extremely popularized as a weight-loss aid. Ozempic contains a compound called ...
Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them experience unpleasant and concerning side effects. In 2024, roughly 5 per ...
These included GLP-1 receptor agonists like Ozempic (which promote insulin production and feelings of fullness); SGLT2 inhibitors (which prevent the kidneys from reabsorbing glucose, forcing its ...
Research out this week might help you plan your own version of the Ozempic diet, with the results of a survey revealing the foods that people tend to avoid, or eat less of, once they start taking ...
The use of weight loss treatments like Ozempic and Wegovy has skyrocketed in the Western world. But as more people turn to these treatments, which mimic the appetite-suppressing hormone GLP-1 ...
He recently wrote a primer on the new injectable weight loss drugs: “Ozempic, Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs.” This column is a summary. GLP-1 is short for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results